Elevated C-reactive protein in the diagnosis, prognosis, and cause of cancer

Publikation: Bidrag til tidsskrift › Tidsskriftartikel › Forskning › fagfællebedømt

Standard

Elevated C-reactive protein in the diagnosis, prognosis, and cause of cancer. / Allin, Kristine H; Nordestgaard, Børge G.

I: Critical Reviews in Clinical Laboratory Sciences, Bind 48, Nr. 4, 2011, s. 155-70.

Publikation: Bidrag til tidsskrift › Tidsskriftartikel › Forskning › fagfællebedømt

Harvard

Allin, KH & Nordestgaard, BG 2011, 'Elevated C-reactive protein in the diagnosis, prognosis, and cause of cancer', Critical Reviews in Clinical Laboratory Sciences, bind 48, nr. 4, s. 155-70. https://doi.org/10.3109/10408363.2011.599831

APA

Allin, K. H., & Nordestgaard, B. G. (2011). Elevated C-reactive protein in the diagnosis, prognosis, and cause of cancer. Critical Reviews in Clinical Laboratory Sciences, 48(4), 155-70. https://doi.org/10.3109/10408363.2011.599831

Vancouver

Allin KH, Nordestgaard BG. Elevated C-reactive protein in the diagnosis, prognosis, and cause of cancer. Critical Reviews in Clinical Laboratory Sciences. 2011;48(4):155-70. https://doi.org/10.3109/10408363.2011.599831

Author

Allin, Kristine H ; Nordestgaard, Børge G. / Elevated C-reactive protein in the diagnosis, prognosis, and cause of cancer. I: Critical Reviews in Clinical Laboratory Sciences. 2011 ; Bind 48, Nr. 4. s. 155-70.

Bibtex

@article{259492b38cb7403f8c0b15ed000a38de,
title = "Elevated C-reactive protein in the diagnosis, prognosis, and cause of cancer",
abstract = "The aim of this review is to summarize present evidence of an association between circulating levels of C-reactive protein (CRP) and cancer risk, and to evaluate whether elevated circulating CRP levels cause cancer. Additionally, the review provides background information on the acute-phase response, chronic inflammation, the molecular biology, function and measurement of CRP, circulating levels of CRP in health and disease, the principle of Mendelian randomization, the association between circulating levels of CRP and cancer prognosis, and cancer biomarkers. In the Copenhagen General Population Study of approximately 63,500 individuals, the distribution of circulating levels of CRP was markedly skewed to the right with 97% of the participants having CRP levels3¿mg/L) had an 80% greater risk of early death compared with those with low CRP levels (3¿mg/L at diagnosis had a 1.7-fold increased risk of death from breast cancer compared to patients with CRP levels",
author = "Allin, {Kristine H} and Nordestgaard, {B{\o}rge G}",
year = "2011",
doi = "http://dx.doi.org/10.3109/10408363.2011.599831",
language = "English",
volume = "48",
pages = "155--70",
journal = "Critical Reviews in Clinical Laboratory Sciences",
issn = "1040-8363",
publisher = "Taylor & Francis",
number = "4",

}

RIS

TY - JOUR

T1 - Elevated C-reactive protein in the diagnosis, prognosis, and cause of cancer

AU - Allin, Kristine H

AU - Nordestgaard, Børge G

PY - 2011

Y1 - 2011

N2 - The aim of this review is to summarize present evidence of an association between circulating levels of C-reactive protein (CRP) and cancer risk, and to evaluate whether elevated circulating CRP levels cause cancer. Additionally, the review provides background information on the acute-phase response, chronic inflammation, the molecular biology, function and measurement of CRP, circulating levels of CRP in health and disease, the principle of Mendelian randomization, the association between circulating levels of CRP and cancer prognosis, and cancer biomarkers. In the Copenhagen General Population Study of approximately 63,500 individuals, the distribution of circulating levels of CRP was markedly skewed to the right with 97% of the participants having CRP levels3¿mg/L) had an 80% greater risk of early death compared with those with low CRP levels (3¿mg/L at diagnosis had a 1.7-fold increased risk of death from breast cancer compared to patients with CRP levels

AB - The aim of this review is to summarize present evidence of an association between circulating levels of C-reactive protein (CRP) and cancer risk, and to evaluate whether elevated circulating CRP levels cause cancer. Additionally, the review provides background information on the acute-phase response, chronic inflammation, the molecular biology, function and measurement of CRP, circulating levels of CRP in health and disease, the principle of Mendelian randomization, the association between circulating levels of CRP and cancer prognosis, and cancer biomarkers. In the Copenhagen General Population Study of approximately 63,500 individuals, the distribution of circulating levels of CRP was markedly skewed to the right with 97% of the participants having CRP levels3¿mg/L) had an 80% greater risk of early death compared with those with low CRP levels (3¿mg/L at diagnosis had a 1.7-fold increased risk of death from breast cancer compared to patients with CRP levels

U2 - http://dx.doi.org/10.3109/10408363.2011.599831

DO - http://dx.doi.org/10.3109/10408363.2011.599831

M3 - Journal article

VL - 48

SP - 155

EP - 170

JO - Critical Reviews in Clinical Laboratory Sciences

JF - Critical Reviews in Clinical Laboratory Sciences

SN - 1040-8363

IS - 4

ER -

ID: 40139097